- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
AKIRIN2 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP17163b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP17163b-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
AKIRIN2 Antibody (C-term) - Product info | |
| Application | WB
|
| Primary Accession | Q53H80 |
| Other Accession | Q25C79, B1AXD8, A8YXY8, NP_060534.1 |
| Reactivity | Human |
| Predicted | Bovine, Mouse, Rat |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 22496 Da |
AKIRIN2 Antibody (C-term) - Additional info | |
| Gene ID 55122 | |
| Other Names AKIRIN2; C6orf166; Akirin-2 | |
| Target/Specificity This AKIRIN2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 176-203 amino acids from the C-terminal region of human AKIRIN2. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions AKIRIN2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
AKIRIN2 Antibody (C-term) - Protein Information | |
| Name AKIRIN2 | |
| Synonyms C6orf166 | |
| Function Required for the innate immune response. Downstream effector of the Toll-like receptor (TLR), TNF and IL-1 beta signaling pathways leading to the production of IL-6. Forms a complex with YWHAB that acts to repress transcription of DUSP1 (By similarity) | |
| Cellular Location Nucleus. | |
| Tissue Location Widely expressed with the highest expression in peripheral blood leukocytes | |
AKIRIN2 Antibody (C-term) - Related products
AP17163b: AKIRIN2 Antibody (C-term)
AKIRIN2 Antibody (C-term) - Application data
-
AKIRIN2 Antibody (C-term) (Cat. #AP17163b) western blot analysis in U937 cell line lysates (35ug/lane).This demonstrates the AKIRIN2 antibody detected the AKIRIN2 protein (arrow).
-
Western blot analysis of AKIRIN2 (arrow) using rabbit polyclonal AKIRIN2 Antibody (C-term) (Cat. #AP17163b). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the AKIRIN2 gene.
AKIRIN2 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Required for the innate immune response. Downstream effector of the Toll-like receptor (TLR), TNF and IL-1 beta signaling pathways leading to the production of IL-6. Forms a complex with YWHAB that acts to repress transcription of DUSP1 (By similarity).
REFERENCES
Komiya, Y., et al. J. Biol. Chem. 283(27):18753-18764(2008) Goto, A., et al. Nat. Immunol. 9(1):97-104(2008) Levy, D., et al. BMC Med. Genet. 8 SUPPL 1, S3 (2007) : Vasan, R.S., et al. BMC Med. Genet. 8 SUPPL 1, S2 (2007) : Olsen, J.V., et al. Cell 127(3):635-648(2006)